Michael Grainger

4 weeks ago | mondaq.com | Sophie McGrath |Arvin Abraham |Anne Stroude |Michael Grainger

A shift in macro conditions is driving deal volume acrossresilient subsectors, but regulatory scrutiny remains a keyheadwind. Following a subdued 2024, healthcare M&A and financingactivity is gaining momentum in 2025. Lower interest rates,stronger credit markets, and a return of private equity capital arefueling deal flow, particularly in scalable, tech-driven sectors.